A meta-analysis finds that mobile health tools, such as apps and text messages, support weight management and improve liver ...
Tenofovir alafenamide (Vemlidy) for the initial treatment of chronic hepatitis B may confer modestly higher rates of complete ...
Scientists at City of Hope have unraveled how citrin deficiency (CD), a rare genetic disorder that prevents the liver from ...
New York, NY – December 16, 2025 – In a landmark advancement in minimally invasive dermatologic surgery, Dr. Cameron Rokhsar, ...
Scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ...
The combination of denifanstat and resmetirom was generally well-toleratedPharmacokinetic (PK) results support further development of the ...
In short, liver cirrhosis is dangerous but not hopeless. Women should know the signs such as extreme tiredness, yellow skin, ...
Morning Overview on MSN
Harvard gut discovery could change how we treat obesity + diabetes
Scientists have long suspected that the trillions of microbes in our intestines quietly steer our weight and blood sugar, but ...
PLT012, a groundbreaking anti-CD36 antibody, enters clinical trials to enhance immune responses in solid tumors, promising ...
Aging taps us on the shoulder in many ways: wrinkles, thinning hair, loss of flexibility, slowing of the brain. But the ...
License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed ...
A new test developed by scientists at Northwestern University could make a big difference in the fight against hepatitis C.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback